Navitas Life Sciences

Advancing Early-Phase Oncology Research Through Clinical Project Management, Site Monitoring and Operational Excellence

Discover how a genome-based, clinical-stage biotech partnered with Navitas Life Sciences to strengthen project management, site monitoring and clinical operations for a complex Phase I/II oncology study.

From integrated project leadership to proactive site management and investigator engagement, see how the right partnership helped maintain study momentum, reduce operational risk and lay the foundation for long-term collaboration.

Highlights

  • Strong investigator relationships
  • Proactive CRA support
  • Responsive clinical operations
  • Seamless study execution
  • Trusted long-term partnership
  • Effective project oversight and cross-functional coordination

Sponsor Feedback

We have had a positive experience working with your team, particularly with respect to site management, investigator communication, and overall responsiveness.

Navitas’ CRA team has established strong relationships with the sites and has been proactive in supporting study execution.

As we look ahead, we are evaluating potential opportunities where Navitas may be able to provide additional support for our programs.

CEO
Global Biopharma, Headquartered in Seoul, South Korea

Explore What Operational Excellence Looks Like in Practice
Whether you're preparing for your first IND study or expanding a growing oncology portfolio, this case study offers practical insights into building resilient clinical operations.

Fill the form and download the case study.

© 2026 Navitas Life Sciences | Privacy Policy